Companies Take Their Products To GB Market Post-Brexit
Approvals Follow In Wake Of EU Marketing Authorizations, With Janssen's COVID-19 Vaccine The Latest
Thirteen of the 20 new active substances that were approved in the EU between January and April this year have also now received regulatory clearance in Great Britain, Pink Sheet analysis finds. New filing procedures have been in place there since 1 January.
